APOE and Alzheimer disease: While several studies have failed to find a consistent association between CSF ApoE and Aβ pathology [49, 50, 51], positive correlations have been noted in specific demographic groups such as women and APOE ε4 carriers [52, 53], suggesting CSF ApoE may serve as a potential early marker for AD in these populations (Table 2).